Videa

HQ
Boston
Total Offices: 2
110 Total Employees
Year Founded: 2018

Videa Company Growth, Stability & Outlook in Boston

Updated on September 08, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Videa and has not been reviewed or approved by Videa.

What's the stability & growth outlook for Videa?

Strengths in revenue momentum, embedded partnerships, and expanding market scope are accompanied by a relative modality breadth gap versus a key competitor. Together, these dynamics suggest the Boston-centered organization is scaling effectively while competing in a tightly contested, innovation-driven category.

Key Insight for Candidates

Defining pattern: hypergrowth at the Boston location, reflected in top regional growth rankings and fueled by oversized DSO rollouts, deep Dentrix integrations, and rapid product expansion from imaging to voice/ambient. Why it matters: expect a fast-paced, resource-backed environment focused on enterprise-scale launches and iterative platform building.

Positive Themes About Videa

  • Strong Revenue Growth: Recent Inc. 5000 recognition—including a top placement nationally and a leading rank within the Boston metro area—points to rapid revenue expansion. Public milestones across 2025–2026 reinforce momentum in customers, product scope, and deployments.
  • Strategic Partnerships: Integrations with Henry Schein One’s Dentrix platforms and marquee DSO relationships (e.g., Heartland Dental, Dentalcorp) are extending distribution and enabling large-scale rollouts. These alliances embed the platform within widely used practice-management ecosystems.
  • Market Expansion: The April 2026 rebrand from VideaHealth to Videa, coupled with launches like Ambient Intelligence, signals expansion from a DSO-centric focus into private practices and broader workflow coverage. Recent enterprise wins and ecosystem integrations further indicate widening market reach.

Considerations About Videa

  • Innovation Gaps: Peers have FDA clearances that span both 2D and 3D/CBCT radiology (e.g., Pearl), while the company’s publicly cited strengths are chiefly in 2D—indicating a relative gap in 3D modality coverage.
NEW
What does AI tell candidates about your employer brand?
Get your free AI reputation report today.
See AI Report
AI Report
AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.
Is This Your Company? Claim Profile